Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up?

When a stock is in a freefall, there's usually a justifiable reason for the decline. But for investors with a high risk tolerance, it could make for a potentially attractive contrarian play. A stock that has fallen to a fraction of its price could possess significant upside if it's able to prove its doubters wrong.One stock that's down big of late is Iovance Biotherapeutics (IOVA -1.28%). Entering trading this week, the healthcare stock has lost close to 60% of its value in the past three months, and it's d ...